Diego Paul Bonel Ayuso

Prof. Diego Paul Bonel Ayuso

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
Diego Paul Bonel AyusoDiego Paul Bonel Ayuso
Diego Paul Bonel Ayuso
JPJavier Pineda-Pampliega
Javier Pineda-Pampliega
PGPaloma Martinez-Aleson Garcia
Paloma Martinez-Aleson Garcia
MFMontserrat Fernández-Muela
Montserrat Fernández-Muela
JVJesús de la Fuente Vázquez
Jesús de la Fuente Vázquez
BIBeatriz Isabel-Redondo
Beatriz Isabel-Redondo
Postbiotics—defined in 2021 by the International Scientific Association of Probiotics and Prebiotics (ISAPP) as preparations of inactivated microorganisms and/or their components that confer health benefits to the host—are a promising tool in veterinary medicine. This systematic review and meta-analysis evaluated their types, mechanisms of action, and physiological effects in dogs. A literature search was conducted in PubMed, Scopus, and Web of Science up to 10 October 2024. Eligible studies included peer-reviewed trials in dogs or mechanistic studies on postbiotics; studies in other species or without peer review were excluded. Risk of bias was assessed, and random-effects meta-analyses were performed when appropriate. Of 157 records, 69 met the inclusion criteria, including 13 in vivo studies in dogs. Meta-analyses of selected outcomes showed no statistically significant differences between postbiotic and control groups. Evidence is limited by small sample sizes, strain heterogeneity, and varied study designs. Despite nonsignificant results, existing evidence from other species suggests that postbiotics improve the gut microbiota composition, modulate immune and inflammatory responses, reduce oxidative stress, and aid in the treatment of chronic conditions such as atopic dermatitis. Taken together with their potential role as an alternative to antimicrobial use, these findings highlight the need for further research in canine health to support the use of postbiotics in the treatment of common canine diseases, either as a standalone therapy or in combination with existing therapeutic options.

21 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Diego Paul Bonel AyusoDiego Paul Bonel Ayuso
Diego Paul Bonel Ayuso
JPJavier Pineda-Pampliega
Javier Pineda-Pampliega
PGPaloma Martinez-Aleson Garcia
Paloma Martinez-Aleson Garcia
MFMontserrat Fernández-Muela
Montserrat Fernández-Muela
JVJesús de la Fuente Vázquez
Jesús de la Fuente Vázquez
BIBeatriz Isabel-Redondo
Beatriz Isabel-Redondo
In 2021, the International Scientific Association of Probiotics and Prebiotics (ISAPP) defined "postbiotics" as preparations of inactivated microorganisms and/or their components that confer health benefits to the host. While this field is still emerging, the potential health benefits of these metabolites have driven rapid advancements in their research and production. In recent years, interest in their veterinary use, particularly in dogs, has been growing, although available information remains limited. The aim of this systematic literature review is to provide an overview of the state of the art regarding the use of postbiotics in dogs, examining the types postbiotics, their different mechanisms of action, their potential effects on canine health, and how they are produced and presented for their use. While the meta-analysis conducted with the initial available data in dogs does not show statistically significant effects of postbiotic supplementation in healthy dogs, existing evidence from other species suggests that postbiotics improve gut microbiota composition, modulate immune and inflammatory responses, reduce oxidative stress, and aid in the treatment of chronic conditions such as atopic dermatitis. Taken together with their potential role as an alternative to antimicrobial use, these findings highlight the need for further research in canine health to support the use of postbiotics into the treatment of common canine diseases, either as a standalone therapy or in combination with existing therapeutic options.